Juvenescence Ltd 4
4 · AgeX Therapeutics, Inc. · Filed May 18, 2023
Insider Transaction Report
Form 4
Juvenescence Ltd
10% Owner
Transactions
- Award
Warrant to Purchase Common Stock
2023-04-25+756,429→ 756,429 totalExercise: $0.66Exp: 2026-04-23→ Common Stock (756,429 underlying)
Footnotes (2)
- [F1]Warrants issued in connection with the draw of loan funds under an Amended and Restated Secured Convertible Promissory Note between the issuer and the reporting person.
- [F2]The warrants are exercisable for shares of the issuer's common stock upon issuance.